UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

Critical reviews in oncology/hematology, 2020-07, Vol.151, p.102978-102978, Article 102978

2020

Volltextzugriff (PDF)

The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer

Clinical lung cancer, 2022-01, Vol.23 (1), p.52-59

2022

Volltextzugriff (PDF)

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.1647-1662

2021

Volltextzugriff (PDF)

Intensity-Modulated Radiotherapy With Concurrent Chemotherapy for Previously Irradiated, Recurrent Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (4), p.1067-1073

2007

Volltextzugriff (PDF)

Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck

Oral oncology, 2012-09, Vol.48 (9), p.887-892

2012

Volltextzugriff (PDF)

Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)

Clinical lung cancer, 2023-03, Vol.24 (2), p.120-129

2023

Volltextzugriff (PDF)

The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments

Lung cancer (Amsterdam, Netherlands), 2018-05, Vol.119, p.7-13

2018

Volltextzugriff (PDF)

Oxaliplatin in First-line Therapy for Advanced Non–Small-Cell Lung Cancer

Clinical lung cancer, 2010, Vol.11 (1), p.18-24

2010

Volltextzugriff (PDF)

EGFR L718V (+)/T790M (–) as a Mechanism of Resistance in Patients with Metastatic Non–small-cell Lung Cancer with EGFR L858R Mutations

Clinical lung cancer, 2021-11, Vol.22 (6), p.e817-e819

2021

Volltextzugriff (PDF)

Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation

Lung cancer (Amsterdam, Netherlands), 2014-05, Vol.84 (2), p.110-115

2014

Volltextzugriff (PDF)

Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types

Biochemical and biophysical research communications, 2018-06, Vol.500 (3), p.621-625

2018

Volltextzugriff (PDF)

Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease

Lung cancer (Amsterdam, Netherlands), 2021-05, Vol.155, p.183-190

2021

Volltextzugriff (PDF)

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors

Cancer treatment reviews, 2014-09, Vol.40 (8), p.990-1004

2014

Volltextzugriff (PDF)

Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative group

Critical reviews in oncology/hematology, 2020-09, Vol.153, p.103033-103033, Article 103033

2020

Volltextzugriff (PDF)

Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study)

Journal of clinical epidemiology, 2020-10, Vol.126, p.1-8

2020

Volltextzugriff (PDF)

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2021-10, Vol.160, p.92-98

2021

Volltextzugriff (PDF)

Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978]

Critical reviews in oncology/hematology, 2020-10, Vol.154, p.103058-103058, Article 103058

2020

Volltextzugriff (PDF)

BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?

Critical reviews in oncology/hematology, 2016-05, Vol.101, p.32-39

2016

Volltextzugriff (PDF)

Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin-America

Clinical lung cancer, 2017-01, Vol.18 (1), p.e71-e79

2017

Volltextzugriff (PDF)

Complete Response of Primary Refractory ALK-Positive Large B-Cell Lymphoma Treated With Single-Agent Nivolumab

Clinical lymphoma, myeloma and leukemia, 2020-03, Vol.20 (3), p.e113-e117

2020

Volltextzugriff (PDF)

Pemetrexed-associated urticarial vasculitis

Lung cancer (Amsterdam, Netherlands), 2006-02, Vol.51 (2), p.247-249

2006

Volltextzugriff (PDF)

Gene Expression Profiling and Non–Small-Cell Lung Cancer: Where Are We Now?

Clinical lung cancer, 2009-05, Vol.10 (3), p.168-173

2009

Volltextzugriff (PDF)

Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2006-09, Vol.53 (3), p.347-353

2006

Volltextzugriff (PDF)

Heat Shock Protein–Based Cancer Vaccines

Hematology/oncology clinics of North America, 2006-06, Vol.20 (3), p.637-659

2006

Volltextzugriff (PDF)

Second-Line Therapy for Non–Small-Cell Lung Cancer

Clinical lung cancer, 2009-03, Vol.10 (2), p.91-98

2009

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(32)
Berichte
(1)

Sprache

Englisch
(32)
Spanisch
(1)

Erscheinungsjahr

n.n

Kollektion

Ingenta E-Journals
(23)
MEDLINE
(22)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(19)
Journals@Ovid
(10)
IngentaConnect Journals
(2)
EZB Electronic Journals Library
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

Intensity-Modulated Radiotherapy With Concurrent Chemotherapy for Previously Irradiated, Recurrent Head and Neck Cancer

Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck

Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)

The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments

Oxaliplatin in First-line Therapy for Advanced Non–Small-Cell Lung Cancer

EGFR L718V (+)/T790M (–) as a Mechanism of Resistance in Patients with Metastatic Non–small-cell Lung Cancer with EGFR L858R Mutations

Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation

Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types

Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors

Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative group

Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study)

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)

Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978]

BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?

Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin-America

Complete Response of Primary Refractory ALK-Positive Large B-Cell Lymphoma Treated With Single-Agent Nivolumab

Pemetrexed-associated urticarial vasculitis

Gene Expression Profiling and Non–Small-Cell Lung Cancer: Where Are We Now?

Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC)

Heat Shock Protein–Based Cancer Vaccines

Second-Line Therapy for Non–Small-Cell Lung Cancer

Aktive Filter

Suchergebnisse filtern